Form 4 for MAZE Maze Therapeutics, Inc.
Accepted 2026-05-18 17:07:29 ET · period of report 2026-05-15 · accession 0001676170-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2026-05-18 17:07 | 2026-05-15 | MAZE | Coloma Jason V | CEO, Dir | S - Sale | $26.00 | -1,938 | 31.0K | -6% | -$50.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | S | D | 1,822 | $26.00 | 381,073 | I Coloma Family Trust | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. (F2) These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees. |
| 2 | Common | Common Stock | 2026-05-15 | S | D | 116 | $26.00 | 31,001 | I The Coloma 2021 Irrevocable Trust | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. (F3) These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees. |